欧盟建议批准Yeytuo,一种每年两次注射的艾滋病毒预防药物。 EU recommends approval for Yeytuo, an injectable HIV preventive drug administered twice yearly.

欧洲药品局建议批准Lenacapavir,这是一种预防艾滋病毒的注射药物,每年可提供两次。 The European Medicines Agency (EMA) has recommended the approval of lenacapavir, an injectable drug for HIV prevention, which could be given twice a year. 该药物以Yeytuo销售,非常有效,可提供长期保护,有可能减少每日服用药片的需要。 Sold as Yeytuo, the drug is highly effective and offers long-lasting protection, potentially reducing the need for daily pills. 该建议如果得到欧洲委员会的接受,可在欧盟、冰岛、挪威和列支敦士登授权使用该药物,为感染艾滋病毒风险者提供新的选择。 The recommendation, if accepted by the European Commission, could authorize the drug in the EU, Iceland, Norway, and Liechtenstein, offering a new option for those at risk of HIV.